By Capitol Associates, Inc.
Senate Republicans and the White House are a Republican COVID-19 relief bill. This legislation is intended to serve a marker for Republicans as they negotiate a bipartisan relief bill with Democrats. Bipartisan negotiations are expected to accelerate after the Republican bill is introduced.
Sen. Lamar Alexander (R-TN) a $15 billion bill aimed at preparing the U.S. for future pandemics. The bill provides states with funding over 10 years to build stockpiles of Personal Protective Equipment (PPE). It also gives funds to U.S.-based vaccine and testing manufacturing facilities.
White House and Federal Agencies
HHS that it will require Provider Relief Fund recipients to report payments exceeding $10,000. Reporting instructions will be released by August 17th. The reporting system will be available to recipients starting October 1st.
The HHS Office for Civil Rights (OCR) guidance reminding healthcare facilities that receive federal financial assistance about their legal obligations to not discriminate against patients based on race and ethnicity.
The National Institutes of Health (NIH) is participant data from a health disparity research project developed in 2018, called “All of Us,” to analyze how social factors like income, family structure, and diet effect COVID-19 infection rates and outcomes in different communities.
Centers for Disease Control and Prevention (CDC) Updates
The CDC released from their Household Pulse Survey, a survey aimed at understanding how American’s are experiencing the pandemic in terms of employment, health, access to healthcare, food security, housing, and education.
The CDC its recommendations regarding isolation periods and precautions adults should take to mitigate the spread of COVID-19. The CDC also its guidance on how to best self-isolate while infected with COVID-19 and when recovered patients can end self-isolation.
Reopening, Vaccine and Treatment
The contract would also allow the U.S. to buy another 500 million doses if they so choose.
A study from the New England Journal of Medicine that COVID-19 antibody levels, especially in more mild cases, begin to decline just three months after infection. This may leave recovered COVID-19 patients vulnerable to reinfection.
Please contact the AHRA Regulatory Affairs Committee with any regulatory questions you may have at email@example.com.